Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Gynecologic Oncology
|
August 23, 2016
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2
Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
Breast Cancer Research : BCR
|
August 4, 2021
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models
Nicole J Chew, Terry C C Lim Kam Sian, Elizabeth V Nguyen, et al.
Journal for Immunotherapy of Cancer
|
January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Atara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
The Lancet. Oncology
|
June 22, 2014
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
JTO Clinical and Research Reports
|
April 20, 2026
Treatment Timeliness in Extensive-Stage SCLC and Impact on Survival: A Registry-Based Observational Study
Alison Hiong, Julien Robinson, Eldho Paul, et al.
JTO Clinical and Research Reports
|
April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry
Rob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
The Journal of Pathology
|
October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary
Atara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
Targeted Oncology
|
November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Nature Medicine
|
July 25, 2024
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Anouk E Hiensch, Johanna Depenbusch, Martina E Schmidt, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Gynecologic Oncology
|
August 23, 2016
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2
Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
Breast Cancer Research : BCR
|
August 4, 2021
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models
Nicole J Chew, Terry C C Lim Kam Sian, Elizabeth V Nguyen, et al.
Journal for Immunotherapy of Cancer
|
January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Atara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
The Lancet. Oncology
|
June 22, 2014
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
JTO Clinical and Research Reports
|
April 20, 2026
Treatment Timeliness in Extensive-Stage SCLC and Impact on Survival: A Registry-Based Observational Study
Alison Hiong, Julien Robinson, Eldho Paul, et al.
JTO Clinical and Research Reports
|
April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry
Rob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Signal Transduction and Targeted Therapy
|
June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
The Journal of Pathology
|
October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary
Atara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
Targeted Oncology
|
November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Nature Medicine
|
July 25, 2024
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Anouk E Hiensch, Johanna Depenbusch, Martina E Schmidt, et al.
Page
of 6